Evidence map›Paper›PMID 32010745›Full record

ArticleEndoscopy international open2020

Anti-reflux mucosal ablation (ARMA) as a new treatment for gastroesophageal reflux refractory to proton pump inhibitors: a pilot study.

Haruhiro Inoue, Mayo Tanabe, Enrique Rodríguez de Santiago, Mary Raina Angeli Abad, Yuto Shimamura, Yusuke Fujiyoshi, Akiko Ueno, Kazuya Sumi, Hideomi Tomida, Yugo Iwaya and 2 more

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in Endoscopy international open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 47 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 1 pooled it
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05570448 narecruitingnot on this mapstarted 2022, after this paper: background citation

Anti-Reflux Endoscopic Therapy Using Argon Plasma Coagulation (AREA) in Gastroesophageal Reflux Disease (GERD) Patients: A Single Center, Randomized, Sham, Controlled Trial (The AREA Study)

TypeinterventionalSponsorMidwest Veterans' Biomedical Research FoundationRan2022 to 2027Enrolled36ConditionsGastro Esophageal RefluxArmsARAT, Sham intervention (control)
NCT05899491 nacompletednot on this mapstarted 2023, after this paper: background citation

Role of ARMA in Selective Subset of Refractory GERD Patients- A Randomized Sham Control Trial.

TypeinterventionalSponsorAsian Institute of Gastroenterology, IndiaRan2023 to 2023Enrolled50ConditionsGERD, Reflux, Reflux EsophagitisArmsARMA, UGI Endoscopy
3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 1 synthesis or guideline pooled it, 96 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Efficacy and Safety of Closure-Focused Anti-Reflux Mucoplasty Compared With Conventional ARMS: A Propensity Score-Matched Study (With Video).Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Phase concept: Novel dynamic endoscopic assessment of intramural antireflux mechanisms (with video).Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society · 2025
    Article
  15. American Society for Gastrointestinal Endoscopy guideline on the diagnosis and management of GERD: methodology and review of evidence.VideoGIE : an official video journal of the American Society for Gastrointestinal Endoscopy · 2025
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Introducing antireflux mucoplasty with valve: a novel endoscopic treatment for GERD.VideoGIE : an official video journal of the American Society for Gastrointestinal Endoscopy · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Haruhiro InoueDigestive Diseases Center, Showa University Koto Toyosu Hospital, Tokyo, Japan.
Mayo TanabeDigestive Diseases Center, Showa University Koto Toyosu Hospital, Tokyo, Japan.
Enrique Rodríguez de SantiagoDigestive Diseases Center, Showa University Koto Toyosu Hospital, Tokyo, Japan.
Mary Raina Angeli AbadDigestive Diseases Center, Showa University Koto Toyosu Hospital, Tokyo, Japan.
Yuto ShimamuraDigestive Diseases Center, Showa University Koto Toyosu Hospital, Tokyo, Japan.
Yusuke FujiyoshiDigestive Diseases Center, Showa University Koto Toyosu Hospital, Tokyo, Japan.
Akiko UenoDigestive Diseases Center, Showa University Koto Toyosu Hospital, Tokyo, Japan.
Kazuya SumiDigestive Diseases Center, Showa University Koto Toyosu Hospital, Tokyo, Japan.
Hideomi TomidaDigestive Diseases Center, Showa University Koto Toyosu Hospital, Tokyo, Japan.
Yugo IwayaDigestive Diseases Center, Showa University Koto Toyosu Hospital, Tokyo, Japan.
Haruo IkedaDigestive Diseases Center, Showa University Koto Toyosu Hospital, Tokyo, Japan.
Manabu OnimaruDigestive Diseases Center, Showa University Koto Toyosu Hospital, Tokyo, Japan.
Showa University · JPShowa University Koto Toyosu Hospital

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID32010745
PMCPMC6976329
OpenAlexW3001470397

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.